Johnson & Johnson COVID-19 Vaccine Information
The CDC and the U.S. Food and Drug Administration (FDA) recommend that use of Johnson & Johnson’s COVID-19 Vaccine resume in the US, after a temporary pause.
Updated April 25, 2021
If you received the Johnson & Johnson COVID-19 vaccine – information you should know:
- Fewer than one per million Johnson & Johnson vaccinations are now under investigation. If there is indeed a risk of blood clots from the vaccine, which has yet to be determined, that risk is extremely low.
The risk of contracting COVID-19 in the United States is far higher.
- Six recipients, all women aged 18-48 in the United States, developed the rare disorder within about two weeks of receiving the Johnson & Johnson COVID-19 vaccine.
- Contact The Family Health Centers if you develop symptoms such as a severe headache, abdominal pain, leg pain or shortness of breath.
- Patients should not be concerned about mild headaches and flu-like symptoms in the first few days after receiving the COVID-19 vaccine. These are common, harmless side effects brought on by the immune system’s production of a defense against the Coronavirus / COVID-19.
Please sign up for the "v-safe after-vaccination check" after you receive the COVID-19 vaccine
V-safe is a smartphone-based tool that uses text messaging and web surveys to provide personalized health check-ins after you receive a COVID-19 vaccination. Through v-safe, you can quickly tell the CDC if you have any side effects after receiving the COVID-19 vaccine. Your personal information in v-safe is protected so that it stays confidential and private.
Use your smartphone to navigate your browser to vsafe.cdc.gov